BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6231604)

  • 1. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shaffer MA
    Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
    Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
    Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of azlocillin in the treatment of Pseudomonas aeruginosa otitis in children].
    Damay M; Ployet MJ; Borderon JC
    Presse Med; 1984 Mar; 13(13):812-4. PubMed ID: 6231601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
    Smith AL; Doershuk C; Goldmann D; Gore E; Hilman B; Marks M; Moss R; Ramsey B; Redding G; Rubio T; Williams-Warren J; Wilmott R; Wilson HD; Yogev R
    J Pediatr; 1999 Apr; 134(4):413-21. PubMed ID: 10190914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
    Bauernfeind A; Petermüller C; Dietzel M
    Infection; 1979; 7(1):21-6. PubMed ID: 422252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.